Ingredient

Nonoxynol-12

Nonoxynol-12 is flagged for pregnancy, breastfeeding, trying to conceive, PCOS and general use. The concern behind the strongest flag is endocrine disruptor and absorbed into the body.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Caution Advised
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
5 of 6
Counting avoid, high risk and medium risk
Irritancy
2 of 5
Higher means more likely to sting or redden
PregnancyCAUTION

Nonoxynol-12 and pregnancy

Caution Advised

Nonoxynol-12 is an ethoxylated surfactant used in cosmetics as an emulsifier and cleansing agent. It helps blend ingredients in lotions, creams, and cleansers. The ingredient belongs to a family of compounds derived from nonylphenol. According to ECHA, nonylphenol ethoxylates can degrade into nonylphenol, which has been identified as a potential endocrine disruptor with estrogen-mimicking properties. While specific pregnancy studies on nonoxynol-12 are limited, related compounds in this family have raised concerns about reproductive effects in animal studies. The potential for hormonal disruption during pregnancy, when fetal development is particularly sensitive to endocrine signals, makes some healthcare providers cautious about these ingredients. There is no explicit guidance from ACOG on nonoxynol-12 in cosmetics, as evidence is insufficient to confirm harm from topical cosmetic use. However, given the theoretical endocrine disruption concerns and availability of safer emulsifier alternatives, some obstetricians suggest choosing products without nonylphenol derivatives during pregnancy as a precautionary approach.

BreastfeedingCAUTION

Nonoxynol-12 and breastfeeding

Caution Advised

This surfactant can be absorbed through the skin in small amounts, and concerns exist about its potential endocrine-disrupting properties. While transfer to breast milk has not been specifically studied, lipophilic compounds with hormonal activity can theoretically pass into milk. The primary concern relates to the ingredient's ability to degrade into nonylphenol, which mimics estrogen. While cosmetic concentrations are low and absorption is limited, some lactation consultants recommend avoiding ingredients with known or suspected endocrine activity during breastfeeding out of caution. No major medical organizations have issued specific guidance on nonoxynol-12 for breastfeeding mothers. Given the availability of alternative emulsifiers without endocrine concerns, many dermatologists suggest choosing products formulated with safer surfactants during the breastfeeding period.

PostpartumSAFE

Nonoxynol-12 and postpartum

Safe to Use

For postpartum women not breastfeeding, the primary concern with nonoxynol-12 is potential skin irritation, particularly if the skin barrier is compromised. The ingredient may cause mild irritation in sensitive individuals. Standard precautions apply: if you experience redness, itching, or irritation when using products containing this ingredient, discontinue use. Choose products with gentler surfactants if your skin is particularly sensitive during the postpartum period.

Trying to ConceiveCAUTION

Nonoxynol-12 and trying to conceive

Caution Advised

Women trying to conceive often aim to minimize exposure to endocrine-disrupting compounds that could theoretically affect hormonal balance and fertility. Nonoxynol-12 can degrade to nonylphenol, which has estrogen-mimicking properties. While there is no direct evidence that cosmetic use of nonoxynol-12 affects fertility, some fertility specialists recommend reducing exposure to known endocrine disruptors during the preconception period. Choosing products with alternative emulsifiers is a simple way to minimize potential hormone-disrupting exposures.

PCOSCAUTION

Nonoxynol-12 and PCOS

Caution Advised

Nonoxynol-12 belongs to a family of compounds that can degrade into nonylphenol, a known xenoestrogen (environmental estrogen mimic). For women with PCOS, who already experience hormonal imbalances, exposure to endocrine-disrupting compounds is a theoretical concern. While topical cosmetic exposure is low compared to dietary or environmental sources, some endocrinologists recommend that women with hormonal conditions minimize exposure to known endocrine disruptors when possible. The estrogen-mimicking properties of nonylphenol could theoretically interfere with hormonal balance. There are no clinical studies specifically examining nonoxynol-12's effects on PCOS symptoms. However, given the availability of alternative emulsifiers without endocrine activity, women with PCOS may prefer to choose products formulated with other surfactants as a precautionary measure.

General UseCAUTION

Nonoxynol-12 and general use

Caution Advised

Nonoxynol-12 is an ethoxylated surfactant used as an emulsifier and cleansing agent in cosmetics. It helps stabilize formulations by allowing oil and water to mix. The ingredient is part of the nonylphenol ethoxylate family. According to ECHA, nonylphenol ethoxylates are classified as hazardous to aquatic life and potential endocrine disruptors. These compounds can break down into nonylphenol, which mimics estrogen and has been shown to affect hormone function in animal studies. While cosmetic concentrations are typically low and skin absorption is limited, concerns exist about cumulative exposure and environmental persistence. The ingredient can also cause mild to moderate skin and eye irritation. The EU has placed restrictions on nonylphenol ethoxylates in various applications due to environmental and health concerns. While not banned in cosmetics, many manufacturers are reformulating to use alternative emulsifiers. If you have sensitive skin or hormonal concerns, consider choosing products with alternative surfactants like polysorbates, lecithin, or plant-derived emulsifiers.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store